| Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study E Vasileiou, CR Simpson, T Shi, S Kerr, U Agrawal, A Akbari, S Bedston, ... The Lancet 397 (10285), 1646-1657, 2021 | 637 | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 540 | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 345 | 2022 |
| First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland CR Simpson, T Shi, E Vasileiou, SV Katikireddi, S Kerr, E Moore, ... Nature medicine 27 (7), 1290-1297, 2021 | 275 | 2021 |
| Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in … U Agrawal, S Bedston, C McCowan, J Oke, L Patterson, C Robertson, ... The Lancet 400 (10360), 1305-1320, 2022 | 183 | 2022 |
| Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test … A Sheikh, S Kerr, M Woolhouse, J McMenamin, C Robertson, ... The Lancet Infectious Diseases 22 (7), 959-966, 2022 | 167 | 2022 |
| Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland: national prospective cohort study of 5.4 million people E Vasileiou, D Bradley, A Chuter, S de Lusignan, A Docherty, D Ford, ... | 164 | 2021 |
| COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2· 57 million people in Scotland (EAVE II): a prospective cohort study U Agrawal, SV Katikireddi, C McCowan, RH Mulholland, ... The Lancet Respiratory Medicine 9 (12), 1439-1449, 2021 | 155 | 2021 |
| COVID-19 content collection A Sheikh, S Kerr, M Woolhouse, J McMenamin, C Robertson The Lancet Infectious Diseases 22 (7), 2022 | 126 | 2022 |
| Physical, cognitive and mental health impacts of COVID-19 following hospitalisation–a multi-centre prospective cohort study PHOSP-COVID Collaborative Group, RA Evans, H McAuley, EM Harrison, ... MedRxiv, 2021.03. 22.21254057, 2021 | 79 | 2021 |
| Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study T Shi, J Pan, SV Katikireddi, C McCowan, S Kerr, U Agrawal, SA Shah, ... The Lancet Respiratory Medicine 10 (2), 191-198, 2022 | 58 | 2022 |
| First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England … S Kerr, M Joy, F Torabi, S Bedston, A Akbari, U Agrawal, J Beggs, ... PLoS Medicine 19 (2), e1003927, 2022 | 55 | 2022 |
| Accelerated waning of the humoral response to COVID-19 vaccines in obesity AA Van Der Klaauw, EC Horner, P Pereyra-Gerber, U Agrawal, WS Foster, ... Nature Medicine 29 (5), 1146-1154, 2023 | 44 | 2023 |
| External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland CR Simpson, C Robertson, S Kerr, T Shi, E Vasileiou, E Moore, ... Thorax 77 (5), 497-504, 2022 | 23 | 2022 |
| Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study C Jackson, ID Stewart, T Plekhanova, PS Cunningham, AL Hazel, ... The Lancet Respiratory Medicine 11 (8), 673-684, 2023 | 20 | 2023 |
| Waning of first-and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales S Kerr, S Bedston, DT Bradley, M Joy, E Lowthian, RM Mulholland, ... International Journal of Epidemiology 52 (1), 22-31, 2023 | 18 | 2023 |
| Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland CR Simpson, S Kerr, SV Katikireddi, C McCowan, LD Ritchie, J Pan, ... Nature Communications 13 (1), 4800, 2022 | 18 | 2022 |
| Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls B Zheng, G Vivaldi, L Daines, OC Leavy, M Richardson, O Elneima, ... The Lancet Regional Health–Europe 29, 2023 | 16 | 2023 |
| BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland I Rudan, T Millington, K Antal, Z Grange, L Fenton, C Sullivan, A Buelo, ... The Lancet Regional Health–Europe 23, 2022 | 16 | 2022 |
| Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study B Raman, C McCracken, MP Cassar, AJ Moss, L Finnigan, AHA Samat, ... The Lancet Respiratory Medicine 11 (11), 1003-1019, 2023 | 15 | 2023 |
